Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6550)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2014 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wei XL, Wang DS, Xi SY, Wu WJ, Chen DL, Zeng ZL, Wang RY, Huang YX, Jin Y, Wang F, Qiu MZ, Luo HY, Zhang DS, Xu RH. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer. World J Gastroenterol 2014; 20(48): 18404-18412 [PMID: 25561809 DOI: 10.3748/wjg.v20.i48.18404] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i48/18404.htm |
| Number | Citing Articles |
| 1 |
TAKASHI TAKEDA, KOUJI BANNO, RYUICHIRO OKAWA, MEGUMI YANOKURA, MOITO IIJIMA, HARUKO IRIE-KUNITOMI, KANAKO NAKAMURA, MIHO IIDA, MASATAKA ADACHI, KIYOKO UMENE, YUYA NOGAMI, KENTA MASUDA, YUSUKE KOBAYASHI, EIICHIRO TOMINAGA, DAISUKE AOKI. ARID1A gene mutation in ovarian and endometrial cancers (Review). Oncology Reports 2016; 35(2): 607 doi: 10.3892/or.2015.4421
|
| 2 |
B. Niedermaier, A. Sak, E. Zernickel, Shan Xu, M. Groneberg, M. Stuschke. Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-54757-z
|
| 3 |
Ning Xu, Lili Wang, Ping Sun, Suyang Xu, Shiping Fu, Zhihua Sun. Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma. Pathology & Oncology Research 2019; 25(3): 875 doi: 10.1007/s12253-017-0338-8
|
| 4 |
Jake J. Reske, Mike R. Wilson, Jeanne Holladay, Rebecca A. Siwicki, Hilary Skalski, Shannon Harkins, Marie Adams, John I. Risinger, Galen Hostetter, Ken Lin, Ronald L. Chandler, David B. Chapel. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis. PLOS Genetics 2021; 17(12): e1009986 doi: 10.1371/journal.pgen.1009986
|
| 5 |
Tasuku Matsuoka, Masakazu Yashiro. Precision medicine for gastrointestinal cancer: Recent progress and future perspective. World Journal of Gastrointestinal Oncology 2020; 12(1): 1-20 doi: 10.4251/wjgo.v12.i1.1
|
| 6 |
Wei Li, Hui Ming, Danyang Sun, Wei Li, Dan Wang, Guizhi Zhang, Jian Tan. The relationship between BRAFV600E, NF-κB and TgAb expression in papillary thyroid carcinoma. Pathology - Research and Practice 2017; 213(3): 183 doi: 10.1016/j.prp.2016.12.022
|
| 7 |
Paula Pellenz Tomasini, Temenouga Nikolova Guecheva, Natalia Motta Leguisamo, Sarah Péricart, Anne-Cécile Brunac, Jean Sébastien Hoffmann, Jenifer Saffi. Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer. Cancers 2021; 13(13): 3130 doi: 10.3390/cancers13133130
|
| 8 |
Rong-Sheng Qin, Chun-Tao Li, Fei Chen, Shu Luo, Chao Wang, Jie Li, Shan Xu, MingWei Kang, Hao-Wen Hu. AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01433-y
|
| 9 |
Yoshihiro Kishida, Takuma Oishi, Takashi Sugino, Akio Shiomi, Kenichi Urakami, Masatoshi Kusuhara, Ken Yamaguchi, Yuko Kitagawa, Hiroyuki Ono. Associations Between Loss of ARID1A Expression and Clinicopathologic and Genetic Variables in T1 Early Colorectal Cancer. American Journal of Clinical Pathology 2019; 152(4): 463 doi: 10.1093/ajcp/aqz062
|
| 10 |
Shankun Zhao, Weizhou Wu, Zufu Jiang, Fuqin Tang, Lingzhi Ding, Weifang Xu, Libin Ruan. Roles of ARID1A variations in colorectal cancer: a collaborative review. Molecular Medicine 2022; 28(1) doi: 10.1186/s10020-022-00469-6
|
| 11 |
Elena Fountzilas, Vassiliki Kotoula, Ioannis Tikas, Kyriaki Manousou, Kyriaki Papadopoulou, Christos Poulios, Vasilios Karavasilis, Ioannis Efstratiou, Dimitrios Pectasides, Kleo Papaparaskeva, Ioannis Varthalitis, Christos Christodoulou, George Papatsibas, Sofia Chrisafi, Georgios K. Glantzounis, Amanda Psyrri, Gerasimos Aravantinos, Georgia-Angeliki Koliou, George K. Koukoulis, George E. Pentheroudakis, George Fountzilas. Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer. Oncotarget 2018; 9(86): 35623 doi: 10.18632/oncotarget.26256
|
| 12 |
Huan Peng, Jun Ying, Jia Zang, Hao Lu, Xiaokai Zhao, Pengmin Yang, Xintao Wang, Jieyi Li, Ziying Gong, Daoyun Zhang, Zhiguo Wang. Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal Cancer. Cancer Research and Treatment 2023; 55(4): 1270 doi: 10.4143/crt.2023.415
|
| 13 |
Lik Hang Lee, Eran Sadot, Sinisa Ivelja, Efsevia Vakiani, Jaclyn F. Hechtman, Christopher J. Sevinsky, David S. Klimstra, Fiona Ginty, Jinru Shia. ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance. Human Pathology 2016; 53: 97 doi: 10.1016/j.humpath.2016.02.004
|
| 14 |
Zihuan Wang, Xu Zhang, Yuchen Luo, Yijiang Song, Cheng Xiang, Yilin He, Kejin Wang, Yingnan Yu, Zhen Wang, Wenxuan Peng, Yi Ding, Side Liu, Changjie Wu. Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis). Cell Death & Disease 2024; 15(5) doi: 10.1038/s41419-024-06751-1
|
| 15 |
David Reisman, Kenneth Thompson, Stefanie Marquez‐Vilendrer, Li Lu. Encyclopedia of Life Sciences. 2016; : 1 doi: 10.1002/9780470015902.a0025738
|
| 16 |
Claudio Luchini, Nicola Veronese, Marco Solmi, Hanbyoul Cho, Jae-Hoon Kim, Angela Chou, Anthony J. Gill, Sheila F. Faraj, Alcides Chaux, George J. Netto, Kentaro Nakayama, Satoru Kyo, Soo Young Lee, Duck-Woo Kim, George M. Yousef, Andreas Scorilas, Gregg S. Nelson, Martin Köbel, Steve E. Kalloger, David F. Schaeffer, Hai-Bo Yan, Feng Liu, Yoshihito Yokoyama, Xianyu Zhang, Da Pang, Zsuzsanna Lichner, Giuseppe Sergi, Enzo Manzato, Paola Capelli, Laura D. Wood, Aldo Scarpa, Christoph U. Correll. Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. Oncotarget 2015; 6(36): 39088 doi: 10.18632/oncotarget.5142
|
| 17 |
Sasithorn Wanna‑Udom, Siripat Aluksanasuwan, Keerakarn Somsuan, Wariya Mongkolwat, Natthiya Sakulsak. ARID1A overexpression inhibits colorectal cancer cell migration through the regulation of epithelial‑mesenchymal transition. Molecular Medicine Reports 2024; 30(5) doi: 10.3892/mmr.2024.13325
|
| 18 |
Jesus García-López, Kirby Wallace, Joel H. Otero, Rachelle Olsen, Yong-dong Wang, David Finkelstein, Brian L. Gudenas, Jerold E. Rehg, Paul Northcott, Andrew M. Davidoff, Kevin W. Freeman. Large 1p36 Deletions Affecting Arid1a Locus Facilitate Mycn-Driven Oncogenesis in Neuroblastoma. Cell Reports 2020; 30(2): 454 doi: 10.1016/j.celrep.2019.12.048
|
| 19 |
Salem Baldi, Hassan Khamgan, Yuanyuan Qian, Han Wu, Zhenyu Zhang, Mengyan Zhang, Yina Gao, Mohammed Safi, Mohammed Al-Radhi, Yun-Fei Zuo. Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.679334
|
| 20 |
Hanyun Liang, Xin Zheng, Xiao Zhang, Yan Zhang, Jie Zheng. The role of SWI/SNF complexes in digestive system neoplasms. Medical Oncology 2024; 41(5) doi: 10.1007/s12032-024-02343-3
|
| 21 |
Mehran Erfani, Seyed Vahid Hosseini, Maral Mokhtari, Mozhdeh Zamani, Kamran Tahmasebi, Mahvash Alizadeh Naini, Alireza Taghavi, John M. Carethers, Minoru Koi, Hassan Brim, Pooneh Mokarram, Hassan Ashktorab. Altered ARID1A expression in colorectal cancer. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6706-x
|
| 22 |
Pui Kei Mou, Eun Ju Yang, Changxiang Shi, Guowen Ren, Shishi Tao, Joong Sup Shim. Aurora kinase A, a synthetic lethal target for precision cancer medicine. Experimental & Molecular Medicine 2021; 53(5): 835 doi: 10.1038/s12276-021-00635-6
|
| 23 |
Ryia Illani Mohd Yunos, Nurul Syakima Ab Mutalib, Francis Yew Fu Tieng, Nadiah Abu, Rahman Jamal. Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine. Biomolecules 2020; 10(3): 476 doi: 10.3390/biom10030476
|
| 24 |
Amir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, Ganiraju C. Manyam, Shailesh M. Advani, Riham Katkhuda, Anuj Verma, Michael Lam, Jason Willis, John Paul Shen, Jeffrey Morris, Jennifer S. Davis, Jonathan M. Loree, Hey Min Lee, Jaffer A. Ajani, Dipen M. Maru, Michael J. Overman, Scott Kopetz. ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clinical Cancer Research 2021; 27(6): 1663 doi: 10.1158/1078-0432.CCR-20-2404
|
| 25 |
Siripat Aluksanasuwan, Keerakarn Somsuan, Sasithorn Wanna‑Udom, Sittiruk Roytrakul, Atthapan Morchang, Artitaya Rongjumnong, Natthiya Sakulsak. Proteomic insights into the regulatory function of ARID1A in colon cancer cells. Oncology Letters 2024; 28(2) doi: 10.3892/ol.2024.14525
|
| 26 |
Mehran Erfani, Mozhdeh Zamani, Seyed Younes Hosseini, Zohreh Mostafavi-Pour, Sayed Mohammad Shafiee, Mohammadreza Saeidnia, Pooneh Mokarram. ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target. Molecular Biology Reports 2021; 48(10): 6749 doi: 10.1007/s11033-021-06671-9
|
| 27 |
Changjie Wu, Junfang Lyu, Eun Ju Yang, Yifan Liu, Baoyuan Zhang, Joong Sup Shim. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells. Nature Communications 2018; 9(1) doi: 10.1038/s41467-018-05694-4
|
| 28 |
Hitomi Yamashita, Kentaro Nakayama, Kosuke Kanno, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Sultana Razia, Tohru Kiyono, Satoru Kyo. Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer. Cancers 2024; 16(11): 1999 doi: 10.3390/cancers16111999
|
| 29 |
Achira Namjan, Anchalee Techasen, Watcharin Loilome, Prakasit Sa-ngaimwibool, Apinya Jusakul. ARID1A alterations and their clinical significance in cholangiocarcinoma. PeerJ 2020; 8: e10464 doi: 10.7717/peerj.10464
|
| 30 |
Salem Baldi, Qianshi Zhang, Zhenyu Zhang, Mohammed Safi, Hassan Khamgan, Han Wu, Mengyan Zhang, Yuanyuan Qian, Yina Gao, Abdullah Shopit, Abdullah Al‐Danakh, Mohammed Alradhi, Murad Al‐Nusaif, Yunfei Zuo. ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression. Journal of Cellular and Molecular Medicine 2022; 26(24): 5984 doi: 10.1111/jcmm.17590
|
| 31 |
Beatrice Fontana, Giulia Gallerani, Irene Salamon, Ilaria Pace, Roberta Roncarati, Manuela Ferracin. ARID1A in cancer: Friend or foe?. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1136248
|
| 32 |
Cristina Colarossi, Marzia Mare, Giorgio La Greca, Marco De Zuanni, Lorenzo Colarossi, Eleonora Aiello, Eliana Piombino, Lorenzo Memeo. Medullary Carcinoma of the Gastrointestinal Tract: Report on Two Cases with Immunohistochemical and Molecular Features. Diagnostics 2021; 11(10): 1775 doi: 10.3390/diagnostics11101775
|
| 33 |
Kelly Offermans, Josien CA Jenniskens, Colinda CJM Simons, Iryna Samarska, Gregorio E Fazzi, Kim M Smits, Leo J Schouten, Matty P Weijenberg, Heike I Grabsch, Piet A van den Brandt. Expression of proteins associated with the Warburg‐effect and survival in colorectal cancer. The Journal of Pathology: Clinical Research 2022; 8(2): 169 doi: 10.1002/cjp2.250
|
| 34 |
Tomoyuki Naito, Hibiki Udagawa, Shigeki Umemura, Tetsuya Sakai, Yoshitaka Zenke, Keisuke Kirita, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Masahiro Tsuboi, Genichiro Ishii, Koichi Goto. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden. Lung Cancer 2019; 138: 35 doi: 10.1016/j.lungcan.2019.10.009
|
| 35 |
Huan Zhou, Shun Tan, Hong Li, Xiangtao Lin. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.9886
|
| 36 |
Kyaw Z. Hein, Bettzy Stephen, Siqing Fu. Therapeutic Role of Synthetic Lethality in ARID1A-Deficient Malignancies. Journal of Immunotherapy and Precision Oncology 2023; doi: 10.36401/JIPO-22-37
|
| 37 |
Ruihua Wang, Mei Chen, Xiaojun Ye, Karen Poon. Role and potential clinical utility of ARID1A in gastrointestinal malignancy. Mutation Research/Reviews in Mutation Research 2021; 787: 108360 doi: 10.1016/j.mrrev.2020.108360
|
| 38 |
Shan Xu, Ali Sak, Ben Niedermaier, Yasin Bahadir Erol, Michael Groneberg, Emil Mladenov, MingWei Kang, George Iliakis, Martin Stuschke. Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.999626
|
| 39 |
Cheng Xiang, Zhen Wang, Yingnan Yu, Zelong Han, Jingyi Lu, Lei Pan, Xu Zhang, Zihuan Wang, Yilin He, Kejin Wang, Wenxuan Peng, Side Liu, Yijiang Song, Changjie Wu. ARID1A loss sensitizes colorectal cancer cells to floxuridine. Neoplasia 2024; 58: 101069 doi: 10.1016/j.neo.2024.101069
|
| 40 |
Evangelia Pavlidou, Vasileios Balis. Diagnostic significance and prognostic role of the ARID1A gene in cancer outcomes (Review). World Academy of Sciences Journal 2020; doi: 10.3892/wasj.2020.37
|
| 41 |
Burak Kinali, Mehmet Senoglu, Fatma Keklik Karadag, Ali Karadag, Erik H. Middlebrooks, Pinar Oksuz, Evren Sandal, Caglar Turk, Gülden Diniz. Hypoxia-Inducible Factor 1α and AT-Rich Interactive Domain-Containing Protein 1A Expression in Pituitary Adenomas: Association with Pathological, Clinical, and Radiological Features. World Neurosurgery 2019; 121: e716 doi: 10.1016/j.wneu.2018.09.196
|